Pharmafile Logo

Hitting Every Beat—The Power of Education in Heart Failure

February 8, 2024 | CME, HFWeek2024, cardiology, heart failure 

- PMLiVE

Heart failure can be a challenge to manage both for clinicians and patients. It’s a complex condition with various manifestations and presentations, and different disease stages that require different approaches to treatment. New approaches are being developed every day, making education on multidisciplinary management of the condition important for all members of the care team.

For decades, Medscape Education has been a trusted and essential resource for keeping clinicians up to date with guideline recommendations and current heart failure treatment strategies to optimize patient outcomes. Medscape’s partnerships with Heart Failure Society of America (HFSA) and the American College of Cardiology (ACC) ensure that the educational information is cutting edge and includes actionable data on advances in clinical care.

In the last year alone, more than 127,000 clinicians have turned to Medscape for a wide range of learning activities, including information on screening tools for iron deficiency, managing patients with worsening heart failure, and advances in remote thoracic fluid monitoring. During the last 12 months, 20,000 clinicians have logged in to Medscape Education to learn more about education on worsening heart failure with reduced ejection fraction.

Clearly, healthcare professionals want to support their patients’ health journey, and they’ll go the extra mile to get the information they need. And Medscape Education is there to guide them.

Medscape supports the use of technology to make a difference in healthcare access, equity, and outcomes. In its simplest form, disseminating educational resources from an online portal means that more clinicians, and subsequently patients, will benefit.

In 2022, for example, online education developed in partnership with HFSA significantly improved cardiologists’ and primary care physicians’ knowledge of the use of sodium-glucose co-transporter 2 inhibitors (SGLT-2)  in the management of heart failure.

The data show that not only do clinicians want and need education around heart failure, but that continuing medical education (CME/CE) on Medscape has a significant impact on healthcare professionals’ knowledge and competence.

“Medscape Education has become a destination for clinicians who need education and resources on the latest treatment options for heart failure, thanks in no small part to our collaboration with amazing partners like HFSA and ACC. Together, we’re able to take an impact-first approach to education and develop programs that will have the biggest impact on clinicians’ knowledge, confidence, and competence, and thus, on patient lives. We’re proud of the work we’ve done together so far, and have much more to come in the future,” said Margaret Harris, PHD Director, Clinical Strategy.

Want to learn more about how Medscape is making an impact in heart failure education? Join us this week on LinkedIn, as we raise awareness for Heart Failure and American Heart health literacy by touching upon our impact on patient outcomes, recent publications at key conferences like ACC and HFSA , and share our demonstrated success at our annual HOC conference last year.

For more on heart failure education or cardiology education at Medscape Education, please contact David Anderson or visit theheart.org

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Leading with Heart: Why Vulnerability is a Force Multiplier

In a world that often prizes "macho" decisiveness, Dr. Lobna Salem (CMO at Viatris) and Dr. Amrit Ray (Board Chairman and former Pfizer executive) are advocating for a more human...

Cardiology Education in the Age of AI: Join Medscape at ACC 2026

  As medical knowledge now doubles every 73 days, the challenge for cardiology clinicians has shifted from finding information to mastering precision. At the American College of Cardiology (ACC) 65th...

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

#ShortenTheJourney

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Why Sleep Health is the Missing Link in Women’s Wellness

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...